A novel SARS-CoV-2 T cell targeting, peptide-based vaccine candidate designed using the iVAX platform by Elena Iemma | Jun 7, 2022 A novel SARS-CoV-2 T cell targeting, peptide-based vaccine candidate designed using the iVAX platform
